A year ago, when the U.S. Justice Department issued guidance urging prosecutors to dismiss allegedly meritless whistleblower cases, defense lawyers cheered what they considered a significant new check on lawsuits alleging fraud against the government.
It didn’t take long for Justice Department lawyers to act on the guidance, which put a new focus on the False Claims Act, a law that allows whistleblowers to bring cases alleging fraud against government programs and keep a portion of any awarded damages. In December alone, the Justice Department moved to dismiss 11 whistleblower lawsuits against pharmaceutical manufacturers.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn